Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZTS vs MRNA✓SelectedUSD · MRNAZTS vs MRNA performance historyLatest closeAs of+2.50%11/18
Stock and ETF performance explorer

ZTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-59.6%
MRNA return
-20.0%
Excess return
-39.6%
Maximum drawdown
-70.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.5%-4.8%+7.3%+2.8%
7D+3.6%-20.9%+24.5%+4.9%
30D+8.2%-13.3%+21.5%+8.9%
3M+16.5%+212.6%-196.1%+4.8%
6M+11.6%+309.0%-297.4%-3.3%
YTD-30.5%+567.3%-597.8%-43.7%
1Y-25.9%+689.7%-715.6%-41.5%
3Y-48.8%+157.4%-206.2%-55.9%
5Y-59.6%-21.7%-37.9%-62.2%
All-59.6%-20.0%-39.6%-62.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling